{
    "organizations": [],
    "uuid": "bd1053ae7eeeb7703ceae5f42ccb0d61ad5279fd",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-glenmark-pharmaceuticals-helsinn-g/brief-glenmark-pharmaceuticals-helsinn-group-enter-into-agreement-for-launch-of-akynzeo-in-india-and-nepal-idUSFWN1RH011",
    "ord_in_thread": 0,
    "title": "BRIEF-Glenmark Pharmaceuticals, Helsinn Group Enter Into Agreement For Launch Of Akynzeo In India And Nepal",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 4 (Reuters) - Glenmark Pharmaceuticals Ltd:\n* SAYS CO, HELSINN GROUP ENTER INTO EXCLUSIVE LICENSING AGREEMENT FOR LAUNCH OF AKYNZEO IN INDIA AND NEPAL\n* SAYS CO WILL HAVE EXCLUSIVE MARKETING RIGHTS FOR AKYNZEO IN INDIA AND NEPAL. Source text - bit.ly/2q38jOE Further company coverage:\n ",
    "published": "2018-04-04T16:45:00.000+03:00",
    "crawled": "2018-04-04T13:55:23.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "glenmark",
        "pharmaceutical",
        "ltd",
        "say",
        "co",
        "helsinn",
        "group",
        "enter",
        "exclusive",
        "licensing",
        "agreement",
        "launch",
        "akynzeo",
        "india",
        "nepal",
        "say",
        "co",
        "exclusive",
        "marketing",
        "right",
        "akynzeo",
        "india",
        "nepal",
        "source",
        "text",
        "company",
        "coverage"
    ]
}